MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia

American Journal of Neuroradiology

Volumn 23, Issue 1, 2002, Pages 27-32

  Hanyu, Haruo ^a   Asano, Tetsuichi ^a   Sakurai, Hirofumi ^a   Tanaka, Yuriko ^a   Takasaki, Masaru ^a   Abe, Kimihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ANTERIOR COMMISSURE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MORPHOLOGY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SUBSTANTIA INNOMINATA; THICKNESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; SUBSTANTIA INNOMINATA;

EID: 0036155777     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
2. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
3. MR anatomy of the substantia innominata and findings in Alzheimer disease: A preliminary study
4. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
5. Cerebral blood flow in dementia
6. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
7. Vascular dementia, diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop
8. Clinical neuropathological criteria for frontotemporal dementia: Lund and Manchester groups
9. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
10. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment
11. The basal nucleus of Meynert revised: The nerve cell number decreases with age
12. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging
13. Stability of neuronal number in the human nucleus basalis of Meynert with age
14. Integrity of the nucleus basalis of Meynert in normal aging
15. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls
16. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease
17. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
18. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease
19. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease
20. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
21. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, Paralysis agitans and Korsakoff's disease
22. Basal forebrain neurons in the dementia of Parkinson's disease
23. Neuron loss in the nucleus basalis of Meynert of Parkinsonism-dementia complex of Guam
24. Neuron loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease
25. Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy
26. Pick's disease (lobar sclerosis): Depletion of neurons in the nucleus basalis of Meynert
27. Alzheimer's disease and Down's syndrome
28. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct
29. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease
30. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia
31. Altered serotonergic and cholinergic synaptic markers in Pick's disease
32. The neurochemistry of vascular dementia
33. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen
34. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
35. Factors influencing contrast in fast spin-echo MR imaging